Sarcopenic Obesity: An Emerging Public Health Problem
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Population aging and the obesity epidemic are important global public health problems that pose an unprecedented threat to the physical and mental health of the elderly and health systems worldwide. Sarcopenic obesity (SO) is a new category of obesity and a high-risk geriatric syndrome in the elderly. SO is associated with many adverse health consequences such as frailty, falls, disability, and increased morbidity and mortality. The core mechanism of SO is the vicious circle between myocytes and adipocytes. In order to implement effective prevention and treatment strategies and reduce adverse clinical outcomes, it is essential to further our understanding of SO in the elderly. Herein, we reviewed the definition, diagnosis, epidemiology, pathogenesis, and treatment of SO in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070 · cited 3×
“The patients with reduced SMM and decreased muscle strength and reduced physical activity are considered to have severe sarcopenia [30].”
BackgroundMethodInfluentialYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 4×
“Aging and Disease • Volume 13, Number 2, April 2022 382 Chen LK, 2019, AWGS2 [30] Use calf circumference, SARC-F or SARC-calf questionnaire to find subjects with sarcopenia DXA:ASM/ht2<7.0kg/m2(M) ASM/ht2<5.4kg/m2(F) BIA:ASM/ht2<7.0kg/m2(M) ASM/ht2<5.7kg/m2(F) Handgrip<28 kg (M) Handgrip<18kg (F) GS<1.0 m/s (6 m), or…”
BackgroundInfluentialSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 2×
“The FHIH recommends the use of DXA to measure SMM, with corrections for BMI [26].”
MethodSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · cited 10×
“The main etiological factors include age-related changes in body composition, sex-specific hormonal changes, chronic low-grade inflammation, insulin resistance, sedentary behavior, and unhealthy diet [5, 10].”
BackgroundMethodInfluentialBody Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Delmonico, M. J., Harris, T. B., Lee, J., Visser, M., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Newman, A. B., & for the Health, A. A. B. C. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01140.x · Cited by 819
Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults
Villareal, D. T., Aguirre, L., Gurney, A. B., Waters, D. L., Sinacore, D. R., Colombo, E., Armamento-Villareal, R., & Qualls, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616338 · Cited by 754
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“38%, or 40%, depending on specific study criteria) [5, 6], and waist circumference higher than the populationspecific quartile [41] or higher than the World Health Organization (WHO)-recommended waist circumference”
BackgroundKim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401
Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264655 · Cited by 401
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis
Gao, Q., Mei, F., Shang, Y., Hu, K., Chen, F., Zhao, L., & Ma, B. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.009 · Cited by 376 · cited 2×
“The incidence of SO in the elderly the world over is about 11%, gradually increased with age [3].”
BackgroundHealthy aging: The ultimate preventative medicine
Kaeberlein, M., Rabinovitch, P. S., & Martin, G. M. (2015) · Science · doi:10.1126/science.aad3267 · Cited by 341
Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
Chen, H., Chung, Y., Chen, Y., Ho, S., & Wu, H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14722 · Cited by 317 · cited 1×
“Aerobic exercise can ameliorate cardiopulmonary function and reduce mortality [5, 67], and resistance training is effective in enhancing muscle function and strength in the elderly [68].”
BackgroundAmerican Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12631 · Cited by 313
Hsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258 · cited 1×
“Aerobic exercise can ameliorate cardiopulmonary function and reduce mortality [5, 67], and resistance training is effective in enhancing muscle function and strength in the elderly [68].”
BackgroundKraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257 · cited 1×
“On the other hand, myocytokines (↓IL-15, ↓irisin, ↓IGF-1, ↑myostatin, impaired IL-6 secretion) may lead to muscle atrophy and dysfunction, they may play an endocrine role to aggravate fatty tissue inflammation and propagate a pro-inflammatory state between myocytes and adipocytes [5,49-52].”
BackgroundSarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Obesity Facts · doi:10.1159/000490361 · Cited by 244 · cited 1×
“In SO, adipocytes accumulate in muscle tissue and other organs (heart, liver and pancreas and so on) and secrete proinflammatory cytokines (TNF-α, IL-6, IL-1 and leptin), thus leading to the infiltration of inflammatory cells and inducing insulin resistance and lipotoxicity, which directly affects skeletal muscle and…”
BackgroundBosy-Westphal, A., Jensen, B., Braun, W., Pourhassan, M., Gallagher, D., & Müller, M. J. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.27 · Cited by 231 · cited 1×
“Bioimpedance analysis (BIA) is a quick and portable technique for measuring body composition [32], which is suitable for large-scale epidemiological investigations and can replace DXA.”
BackgroundDiabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Exercise and nutrition strategies to counteract sarcopenic obesity
Trouwborst, I., Verreijen, A., Memelink, R., Massanet, P., Boirie, Y., Weijs, P., & Tieland, M. (2018) · Nutrients · doi:10.3390/nu10050605 · Cited by 210 · cited 2×
“Resistance training should aim to achieve fatigue rather than exhaustion to prevent musculoskeletal injury [60, 69].”
BackgroundPapanicolaou, D. A., Ather, S. N., Zhu, H., Zhou, Y., Lutkiewicz, J., Scott, B. B., & Chandler, J. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0335-x · Cited by 196
Joseph, A., Adhihetty, P. J., & Leeuwenburgh, C. (2016) · The Journal of Physiology · doi:10.1113/jp270659 · Cited by 186 · cited 1×
“to counteract one or more of the biological effects of SO and has been demonstrated to promote insulin sensitivity [7, 64], reduce oxidative stress [65], induce mitochondrial biosynthesis, ameliorate inflammation, and eliminate muscle cell apoptosis, among other positive effects [5, 58, 63-66].”
BackgroundWaters, D. L., & Baumgartner, R. N. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.007 · Cited by 185
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184 · cited 2×
“Although many emerging pharmacological interventions have been studied, such as testosterone supplementation [13], selective androgen receptor modulators [14], myostatin inhibitors [15], and anti-obesity drugs [5, 6], there are no approved drugs for the treatment of SO in the elderly.”
BackgroundPhysical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177 · cited 1×
“to counteract one or more of the biological effects of SO and has been demonstrated to promote insulin sensitivity [7, 64], reduce oxidative stress [65], induce mitochondrial biosynthesis, ameliorate inflammation, and eliminate muscle cell apoptosis, among other positive effects [5, 58, 63-66].”
BackgroundSarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176
Ryu, M., Jo, J., Lee, Y., Chung, Y.-S., Kim, K.-M., & Baek, W.-C. (2013) · Age and Ageing · doi:10.1093/ageing/aft063 · Cited by 168
Freiberger, E., Goisser, S., Porzel, S., Volkert, D., Kemmler, W., Sieber, C., & Bollheimer, C. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s82454 · Cited by 162
Verschueren, S. M., Bogaerts, A., Delecluse, C., Claessens, A. L., Haentjens, P., Vanderschueren, D., & Boonen, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.181 · Cited by 148
Rivas, D. A., McDonald, D. J., Rice, N. P., Haran, P. H., Dolnikowski, G. G., & Fielding, R. A. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00198.2015 · Cited by 132
Kendler, D. L., Borges, J. L. C., Fielding, R. A., Itabashi, A., Krueger, D., Mulligan, K., Camargos, B. M., Sabowitz, B., Wu, C.-H., Yu, E. W., et al. (2013) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2013.08.020 · Cited by 121 · cited 1×
“Dualenergy X-ray absorptiometry (DXA) is a reliable technique for body composition analysis owing to its safety, repeatability, and accuracy; however, it is associated with a risk of radiation exposure [31].”
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Murton, A. J., Marimuthu, K., Mallinson, J. E., Selby, A. L., Smith, K., Rennie, M. J., & Greenhaff, P. L. (2015) · Diabetes · doi:10.2337/db15-0021 · Cited by 97
Sarcopenic obesity: satellite cells in the aging muscle
Thornell, L.-E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412260 · Cited by 86 · cited 2×
“to counteract one or more of the biological effects of SO and has been demonstrated to promote insulin sensitivity [7, 64], reduce oxidative stress [65], induce mitochondrial biosynthesis, ameliorate inflammation, and eliminate muscle cell apoptosis, among other positive effects [5, 58, 63-66].”
BackgroundSarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86
Self-citationSarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83 · cited 1×
“The core biological factors leading to SO are changes in body composition related to aging, hormonal changes, the interplay between metabolism and inflammation, environmental factors (unhealthy diet and lack of exercise), and chronic diseases [5, 6, 11, 44].”
BackgroundRole of the Cytokine-like Hormone Leptin in Muscle-bone Crosstalk with Aging
Hamrick, M. W. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.1 · Cited by 77 · cited 4×
“The decrease in IGF-1 and age-related testosterone levels increases the incidence of frailty [57].”
BackgroundInfluentialBatsis, J. A., Zbehlik, A. J., Pidgeon, D., & Bartels, S. J. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0118-9 · Cited by 74
Neto, W. K., Gama, E. F., Rocha, L. Y., Ramos, C. C., Taets, W., Scapini, K. B., Ferreira, J. B., Rodrigues, B., & Caperuto, É. (2015) · AGE · doi:10.1007/s11357-014-9742-0 · Cited by 64 · cited 2×
“Although many emerging pharmacological interventions have been studied, such as testosterone supplementation [13], selective androgen receptor modulators [14], myostatin inhibitors [15], and anti-obesity drugs [5, 6], there are no approved drugs for the treatment of SO in the elderly.”
BackgroundIntramyocellular lipid droplets and insulin sensitivity, the human perspective
Gemmink, A., Goodpaster, B. H., Schrauwen, P., & Hesselink, M. K. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.010 · Cited by 62
Yeap, B. B., Paul Chubb, S. A., Lopez, D., Ho, K. K. Y., Hankey, G. J., & Flicker, L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12052 · Cited by 53
Inflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41 · cited 7×
“Further, the dietary pattern of elderly people, which is often characterized by insufficient protein intake combined with excess dietary calorie intake that is rich in saturated fatty acids, coupled with a sedentary lifestyle promotes the occurrence of sarcopenic obesity [11].”
BackgroundInfluentialTherapeutic strategies for sarcopenic obesity: a systematic review
Poggiogalle, E., Parrinello, E., Barazzoni, R., Busetto, L., & Donini, L. M. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000714 · Cited by 32
Cited by
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People
Benz, E., Pinel, A., Guillet, C., Capel, F., Pereira, B., De Antonio, M., Pouget, M., Cruz-Jentoft, A. J., Eglseer, D., Topinkova, E., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3604 · Cited by 261
Barreto Silva, M. I., Picard, K., & Klein, M. R. S. T. (2022) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000871 · Cited by 36
Training modalities for elder sarcopenic obesity: a systematic review and network meta-analysis
Qiu, H., Zheng, W., Zhou, X., Liu, Q., & Zhao, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1537291 · Cited by 17
Fitch, A., Gigliotti, L., & Bays, H. E. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100205 · Cited by 14
“…(i.e. inadequate protein/nutrient intake), low-grade inflammation, oxidative stress, insulin resistance, and hormonal imbalances which independently and synergistically impact both muscle mass and fat tissue resulting in a decline in muscle mass and strength and a gain in adipose tissue [59,61].”
InfluentialPellegrini, M., Itani, L., Rossi, A. P., Kreidieh, D., El Masri, D., Tannir, H., & El Ghoch, M. (2022) · Healthcare · doi:10.3390/healthcare10102042 · Cited by 11
“SO is a phenotype that should be considered in a “real-world” clinical setting, particularly among young and middle-aged adults with obesity [43].”
Background
Metadata
- Authors
- Ji, T., Li, Y., & Ma, L.
- Venue
- Aging and disease
- Publisher
- Aging and Disease
- Published
- 2022
- Volume
- 13
- Issue
- 2
- Pages
- 379
- ISSN
- 2152-5250 (ISSN-L)
- OpenAlex
- W4226052803
- Cited by
- 124
- References
- 54
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.